Previous Article | Next Article 
Molecular and Cellular Biology, July 2000, p. 4970-4978, Vol. 20, No. 14
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Histone Binding Protein RbAp48 Interacts with a
Complex of CREB Binding Protein and Phosphorylated CREB
Qinghong
Zhang,
Ngan
Vo, and
Richard H.
Goodman*
Vollum Institute, Oregon Health Sciences
University, Portland, Oregon
Received 7 December 1999/Returned for modification 13 January
2000/Accepted 24 April 2000
 |
ABSTRACT |
A CREB-CREB binding protein (CBP) complex was used as bait to
screen a mouse embryo cDNA library in yeast. One of the strongest interactions identified the histone binding protein RbAp48. RbAp48 also
interacted weakly with CBP alone but did not interact with phosphorylated or nonphosphorylated CREB. CBP (or its homologue p300)
from HeLa cell nuclear extracts coimmunoprecipitated with RbAp48 and
its homologue RbAp46 and bound to a glutathione
S-transferase-RbAp48 fusion protein. This interaction was
stimulated by the addition of phosphorylated CREB and allowed the
association of core histones and mononucleosomes in an
acetylation-dependent manner. RbAp48 lowered the
Km of CBP histone acetylase activity and
facilitated p300-mediated in vitro transcription of a chromatinized
template in the presence of acetylcoenzyme A. These data indicate that the association of phosphorylated CREB with CBP promotes the binding of
RbAp48 and its homologue RbAp46, allowing the formation of a complex
that facilitates histone acetylation during transcriptional activation.
 |
INTRODUCTION |
The signaling mechanism responsible
for activating genes through the cyclic-AMP-regulated enhancer (CRE)
represents one of the most intensively studied transcriptional pathways
(27). Following the activation of certain G protein-coupled
receptors, the catalytic subunit of protein kinase A (PKA) is released
from the regulatory subunit and is transported to the cell nucleus, where it phosphorylates a unique site in the CRE binding transcription factor CREB. CREB is phosphorylated at this same site by many additional protein kinases, including those activated by
calcium-calmodulin and growth factors. Thus, the transcription factor
CREB has been proposed to serve as a fairly general signal-activated
transcriptional mediator, linking a variety of signal transduction
pathways to genes containing CRE sequences (40).
Phosphorylation allows CREB to interact with the coactivator CREB
binding protein (CBP) or its homologue p300 (6, 7). CBP
associates with a wide variety of additional transcriptional activators
as well, suggesting that it serves as a transcriptional "integrator" (for a review, see reference 42).
Thus, there appears to be a hierarchy of posttranscriptional
modifications and protein-protein interactions that permit
transcriptional signal integration
extracellular signals of various
types converge on the CREB transcription factor, and distinct
transcription factors converge by simultaneously interacting with CBP.
How CBP transmits the activation signal to gene promoters remains
unresolved. Evidence from several laboratories has suggested that CBP
interacts with the basal transcription factors TFIIB and TFIID (8,
21, 44). In addition, Nakajima et al. have shown that CBP
contacts the RNA polymerase II holoenzyme through interactions with RNA
helicase A (29). Thus, one model for CBP function is to
bridge DNA binding transcription factors to components of the basal
transcriptional machinery. Alternatively, CBP might alter some of these
proteins through posttranslational modifications (15).
Other evidence suggests that transcriptional activation mediated
through CBP occurs only in the context of chromatin (19, 20). The involvement of chromatin in CBP function is consistent with the findings that this coactivator and several associated proteins, including PCAF, SRC-1, and pCIP, have the ability to acetylate the amino-terminal tails of histone proteins in a manner that
may lead to some, as-yet-uncharacterized, change in nucleosome structure (2, 5, 30, 43, 47, 53). A multistep model initially proposed by Roeder and coworkers suggests that CBP
contributes to the first step of transcriptional initiation while other
coactivator complexes, such as TRAP, DRIP, and ARC, mediate subsequent
steps (10, 28, 36). More recent evidence suggests that p300
functions at a stage subsequent to chromatin disruption
(23).
Of all the transcription factor-CBP associations, only the interaction
with phosphorylated CREB has been studied in detail. Nuclear magnetic
resonance analysis has revealed that the interaction of the two
proteins introduces structure into both components of the complex
(37). After binding to CBP, phosphorylated CREB adopts a
bihelical configuration with the helical axes approximately perpendicular to one another. One prediction from this finding is that
new protein interaction surfaces might be generated upon CREB-CBP
binding. We have taken advantage of this possibility by developing a
yeast "three-hybrid" assay that uses a CREB-CBP complex to screen
cDNA expression libraries. Such a screen is possible because the PKA
site in CREB is phosphorylated in yeast and allows the CREB-CBP
interaction (41). In this report, we describe an interaction
of the phosphorylated CREB-CBP complex with histone binding protein RbAp48.
RbAp48 and its homologue RbAp46 were initially identified as
retinoblastoma binding proteins (35). Subsequently, these
proteins were characterized as components of at least four distinct
nucleosome-modifying complexes, the nuclear histone deacetylases
(HDACs), the Drosophila nucleosome-remodeling factor NURF,
chromatin assembly factor 1 (CAF-1), and Hat1, a type B (cytoplasmic)
histone acetylase involved in chromatin assembly (13, 18, 25, 33,
46, 49, 51, 55). In general, the functions of the RbAp48-like
proteins in these complexes remain undetermined. Two exceptions to this
generalization are in the context of the human cytoplasmic histone
acetyltransferase Hat1 or its yeast homologue Hat1p, where RbAp46 and
Hat2p appear to link the enzymes to their target, histone H4 (33,
50). Thus, although RbAp48 association with nuclear
transcriptional coactivators has not been described, there is abundant
evidence that these histone binding factors interact with related
classes of proteins. Moreover, this function is consistent with the
model in which a critical function of transcriptional coactivators is to direct the targeting of histone acetyltransferases to specific promoters.
Our studies demonstrate that the association of RbAp48 with the
coactivator CBP is stimulated by phosphorylated CREB. The binding of
RbAp48 to the CREB-CBP complex then allows an interaction with core
histones and mononucleosomes. The binding of histone particles to the
CBP-RbAp48 complex depends upon their acetylation state
acetylation by
CBP blocks the ability of histones or mononucleosomes to associate with
the coactivator. In addition, RbAp48 increases the histone
acetyltransferase activity of CBP, probably by enhancing the affinity
of the coactivator for its substrate. This ability of RbAp48 to
increase CBP histone acetyltransferase activity is reflected by its
capacity to stimulate p300-mediated transcription of a reconstituted
chromatin template in vitro. Furthermore, this stimulation is enhanced
by the addition of acetyl coenzyme A (AcCoA), supporting the functional
significance of RbAp48-targeted histone acetylation.
 |
MATERIALS AND METHODS |
Plasmids.
The bait plasmid for the three-hybrid screen was
constructed from the pBTMYeA backbone. The parental plasmid pBTM116 was
a gift from Stan Hollenberg (Oregon Health Sciences University), and
pAD4 was obtained from Michael Wigler (Cold Spring Harbor Laboratory).
The plasmid pYeA was created by digesting the alcohol dehydrogenase
promoter, polylinker, and terminator from pAD4 with BamHI
and cloning them into pYEP24 (New England Biolabs). To create pBTMYeA,
the alcohol dehydrogenase promoter, terminator, and polylinker of pYeA
were digested with BamHI, blunt ended, and cloned into the
PvuII site of pBTM116. To generate the three-hybrid bait
plasmid, VP16-CREB1-283 (41) was digested with
BamHI and ligated into the BamHI site of pBTMYeA.
LexA-CBP461-682 (41) was digested with
EcoRI and BamHI, blunt ended, and ligated into
the LexA-CREBYeA plasmid using a NotI linker, creating
LexA-CREB-YeACBP. LexA-CREBM1 encodes amino acids (aa) 1 to 283 and
contains a Ser133Ala mutation. The remaining bait plasmids
used in secondary screens were generated similarly. An E9.5 mouse
embryo VP16 fusion cDNA library was a gift from Stan Hollenberg. The
carboxyl-terminal portion of RbAp48 recovered from the library screen,
aa 273 to 425, was subcloned into pGEXKG (Pharmacia) and pET28a
(Novagen) by PCR. Full-length RbAp48 and RbAp46 in pGEX2T3 were
obtained from Bruce Stillman (Cold Spring Harbor Laboratory) and
subcloned into pET28a by PCR. pGEXKG-CBP551-682 was kindly
provided by Roland Kwok (University of Michigan).
Proteins.
Glutathione S-transferase
(GST)-RbAp48273-425, GST-RbAp48, and
GST-CBP551-682 were expressed in bacteria and purified by
glutathione-Sepharose affinity chromatography (Sigma).
His-tagged RbAp48, RbAp46, or RbAp48273-425 was
expressed in strain BL21(DE3) and purified by Ni-nitrilotriacetic acid
affinity chromatography (Qiagen). HeLa cell nuclear extracts were
prepared from HeLa-S3 cells provided by the National Cell Culture
Center, Minneapolis, Minn. (1). CREB in which all of the
cysteines were mutated to serines was purified as described previously
(38) and phosphorylated with PKA for 1 h at 30°C as
described by Laurance et al. (22). PKA was a gift from
Richard Maurer (Oregon Health Sciences University). Flag-tagged CBP and
p300 were expressed in baculovirus-infected SF9 cells and purified
using an M2 Flag affinity matrix (Sigma). Core histone octamers were
isolated from chicken blood (9). Mononucleosomes were
generated by digestion of purified chicken chromatin with micrococcal
nuclease (Sigma), 2 U/ml, in 0.3 mM CaCl2 at 37°C for 40 min. Precautions were taken to avoid overdigestion of the chicken
chromatin to minimize the production of free core histones. The chicken
core particles were confirmed to be hypoacetylated by TAU gel analysis
as described by Tse et al. (48). Gal4-VP16 was expressed in
Escherichia coli and purified as previously described (31).
Yeast three-hybrid screen.
The LexA-CREB-YeACBP bait plasmid
was transformed into the L40 yeast strain using standard small-scale
transformation protocols (14, 39). This bait strain was then
subsequently transformed with approximately 50 µg of the library
plasmid. The yeast cells were allowed to grow at 30°C on Leu-, Trp-,
His-, Ura-, and Lys-deficient plates, and colonies were picked daily
for
-galactosidase assays. Plasmids from yeast that were positive
for production of both histidine and
-galactosidase were isolated
and sequenced. Secondary screens were performed using LexA-CREB,
LexA-CBP, LexA-CREBM1, and LexA-CREBM1-YeACBP as bait.
GST pull-down assays.
GST, GST-RbAp48273-425,
GST-RbAp48, and GST-CBP551-682 were coupled to
glutathione-Sepharose beads (Pharmacia) and blocked with bovine serum
albumin (BSA). Equimolar amounts of GST or GST fusion proteins were
used in pull-down assays. HeLa cell nuclear extracts, recombinant
RbAp48 or RbAp46, purified CREB, phosphorylated CREB, chicken core
histones, and mononucleosomes were added to binding buffer HEG100 (20 mM HEPES [pH 7.6], 10% glycerol, 100 mM KCl, 1 mM EDTA, 1 mM
dithiothreitol, 10 µM NaF, 10 µM Na3VO4)
plus protease inhibitors (Complete; Boehringer Mannheim) for 1 h
at 4°C. The beads were washed three times with HEG100 buffer, boiled
in 15 µl of 5× sodium dodecyl sulfate (SDS) loading buffer, and
electrophoresed on an SDS-6 to 15% polyacrylamide gel. After transfer
to a polyvinylidene difluoride membrane, the bound fraction was
detected by Western blotting using anti-CBP451-682 (which
recognizes both CBP and p300), anti-CREB (New England Biolabs), anti-RbAp48/46 15G12 (GeneTex), or anti-histone H4 BWA3 and
anti-histone H3 LG2-1 (generous gifts from Marc Monestier, Temple
University) antibodies.
Coimmunoprecipitations.
Anti-RbAp48 or anti-RbAp46 antibody
15G12 was coupled to protein G-Sepharose (Pharmacia) and blocked with
BSA. The beads were used to precipitate RbAp48 from HeLa cell nuclear
extracts in HEG100 buffer for 1 h at 4°C. Normal mouse
immunoglobulin G (Sigma) served as a control for background binding.
The beads were washed three times with HEG100 buffer, boiled in 15 µl
of 5× SDS loading buffer, and electrophoresed on an SDS-6%
polyacrylamide gel. After transfer to a polyvinylidene difluoride
membrane, the bound fraction was assayed for CBP by Western blotting
using anti-CBP451-682 antibody.
Histone acetylation assays.
A 0.2-pmol sample of full-length
CBP was preincubated with 1 pmol of His-tagged RbAp48 protein or BSA
(used as a control) in HEG100 buffer on ice for 30 min and then mixed
with purified chicken core histones or mononucleosomes in 30 µl of a
reaction buffer containing 10 mM Tris-HCl (pH 8.0), 10% glycerol, 0.1 mM EDTA, 10 mM sodium butyrate, and [3H]AcCoA (Amersham)
and incubated for 30 min at 30°C. The entire reaction mixture was
spotted onto a phosphocellulose filter (Gibco BRL). The filter was then
washed three times with sodium bicarbonate buffer, and the
3H signal from the transferred acetyl group was quantified
by scintillation. CBP autoacetylation was subtracted from the total counts.
Chromatin assembly and in vitro transcription assays.
S190
extracts and Drosophila core histones were generous gifts
from W. Lee Kraus (Cornell University). The DNA template containing five Gal4 DNA-binding sites upstream from the adenovirus major late
promoter (MLP) encoding a 390-nucleotide (nt) G-free transcription cassette (26) and the Gal4-VP16 construct were gifts from
Danny Reinberg (University of Medicine and Dentistry of New Jersey). The control DNA template encoding a 170-nt G-free transcription cassette placed downstream from the adenovirus MLP was a gift from
Richard Maurer (Oregon Health Sciences University).
Chromatin was assembled as previously described (17, 31).
Gal4-VP16 (200 nM) was added to the reaction mixture subsequent to
chromatin assembly, and the mixture was incubated for 30 min. Where
indicated, full-length p300 (25 nM) was added after Gal4-VP16 and this
remodeled assembly mixture was incubated for a further 30 min at
30°C. The chromatin was then purified over a Sepharose CL-4B column (Pharmacia).
In vitro transcription reactions were performed with HeLa cell nuclear
extracts as previously described (31). Briefly, naked or
chromatinized DNA was incubated with nuclear extracts in the presence
or absence of recombinant RbAp46 (272 nM) and AcCoA (1 µM) for 30 min
at 30°C. The templates were then transcribed at 30°C for 45 min
upon the addition of ribonucleoside triphosphates and RNase
T1. The adenovirus MLP-driven 170-nt template was added to
the transcription mixture as an RNA recovery control. The purified RNA
products were resolved on a 5% acrylamide-6 M urea gel and analyzed
by autoradiography.
 |
RESULTS |
Identification of RbAp48 by a yeast three-hybrid screen.
Although the yeast two-hybrid assay has identified many important
protein-protein interactions, the high false-positive rate often limits
its usefulness as a screening approach. This has particularly been the
case for the transcriptional coactivator CBP (unpublished
observations). One mechanism for generating spurious interactions could
result if the bait component is capable of adopting a variety of
three-dimensional configurations. As discussed above, the association
of phosphorylated CREB with CBP introduces secondary structure into
both components of the complex. Thus, this interaction might stabilize
structures that are important for specific protein-protein interactions
and decrease the occurrence of nonphysiological protein configurations.
Alternatively, the association of phosphorylated CREB and CBP may
generate new protein interaction surfaces that are not found in either
component in isolation. It is possible that critical transcriptional
effectors interact with CBP only, or preferentially, in the context of
these novel induced structures. We have taken advantage of these
possibilities by developing a yeast three-hybrid assay that uses a
CREB-CBP complex as bait.
We had previously shown that LexA-CREB (containing the activation
domain of CREB1-283 fused to the LexA DNA binding domain)
becomes phosphorylated at Ser133 in yeast, thereby
allowing an interaction with VP16-CBP (41).
Ser133 is the residue that is recognized by PKA and other
kinases that have the ability to mediate CREB activation. Mutation of
Ser133 to Ala (designated LexA-CREBM1) prevented the
interaction, supporting the idea that CBP binding to the CREB
activation domain in yeast depends upon phosphorylation. The
kinase responsible for this phosphorylation event is unknown,
although it could be PKA, which is constitutively active in yeast
(41). To develop the yeast three-hybrid assay, we cloned
LexA-CREB and a nucleus-localized fragment of CBP (representing the
CREB binding domain, aa 461 to 682, fused to the simian virus 40 Tag
nuclear localization signal) into plasmid BTMYeA, a derivative of
pYeA (Fig. 1a). The two fusion proteins
were cloned into the same expression vector to reduce the use of
selectable markers and to ensure that the expression ratio of both
components of the bait remained constant. The two-component bait
plasmid (LexA-CREB-YeACBP) was introduced into yeast strain L40 and
used to screen a VP16-cDNA library representing embryonic day 9.5 mouse
mRNAs. In marked contrast to our results obtained by using the same
fragment of CBP in standard two-hybrid assays, which have shown very
little selectivity, virtually all of the cDNAs obtained by using the yeast three-hybrid screen encoded proteins involved in transcriptional regulation (unpublished observation).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Yeast three-hybrid screen. (a) Illustration of
two-component bait plasmid LexA-CREB-YeACBP. LexA-CREB (containing the
activation domain of CREB, aa 1 to 283, fused to the LexA DNA binding
domain) and a nucleus-localized fragment of CBP (representing the CREB
binding domain, aa 461 to 682) were cloned into plasmid pBTMYeA, a
derivative of pYeA. The bait plasmid is ampicillin resistant and
enables Trp production. P, promoter; T, terminator; NLS, nuclear
localization signal. (b) Interaction of VP16-RbAp48 with the CREB-CBP
complex and CBP alone but not with CREB. LexA-CBP, LexA-CREB, and
LexA-CREBM1 are LexA fusion constructs encoding aa 461 to 682 of CBP,
aa 1 to 283 of CREB, or aa 1 to 283 of CREB with a
Ser133Ala mutation, respectively. LexA-CREBM1-YeACBP is a
two-component bait plasmid identical to LexA-CREB-YeACBP with the
exception of the described Ser133Ala mutation. The levels
of interaction with VP16-RbAp48, indicated by the plus and minus signs,
were determined by assaying the growth of the transformants on a
His-negative background.
|
|
One of the strongest positives identified in the screen was the histone
recognition factor RbAp48 (Fig. 1b). When subjected to a secondary
screen, VP16-RbAp48 was found to bind weakly to LexA-CBP alone but did
not interact with LexA-CREB, LexA-CREBM1, or LexA-CREBM1-YeACBP
(Fig. 1b). These studies indicate that the interaction requires
the CBP component. Because the CBP fragment does not bind to DNA,
association with the LexA-CREB component is required to generate an
efficient target for VP16-RbAp48. It is not possible in these assays to
assess the absolute affinities of the interactions of VP16-RbAp48 with
LexA-CBP and LexA-CREB-YeACBP, however, because the two bait plasmids
confer different levels of background activity.
Interaction between RbAp48 and CBP in mammalian cells.
The portion of RbAp48 isolated in the yeast three-hybrid screen
extended from residue 273 to residue 425, which includes
carboxyl-terminal WD repeats 4 through 7. A GST
fusion protein containing this portion of RbAp48,
GST-RbAp48273-425, and a GST protein containing full-length RbAp48 were expressed in bacteria, coupled to
glutathione-agarose beads, and incubated with HeLa cell nuclear
extracts. Both GST-RbAp48 fusion proteins bound to full-length CBP, as
determined by Western blotting using an antibody directed against the
CREB binding domains of CBP and its homologue p300 (Fig.
2a), confirming the interaction identified in yeast. No binding of CBP was detected in the presence of
GST alone. The amino-terminal portion of RbAp48 was incapable of
binding to CBP (data not shown). To determine whether the interaction of CBP and RbAp48 exists in vivo, we immunoprecipitated HeLa cell nuclear extracts with a monoclonal antibody directed against RbAp48 and
performed a Western blot assay using an antibody directed against CBP
(Fig. 2b). These studies showed that RbAp48 complexes contain CBP.
Although these experiments suggest that the association of CBP and
RbAp48 occurs in vivo, they do not show that the interaction is direct.
Moreover, it is possible that some unknown component of the extracts,
such as a transcription factor, could promote the appropriate CBP
interaction interface to allow RbAp48 binding.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Interaction between RbAp48 and CBP in HeLa cells. (a)
GST pull-down assay. A GST fusion protein encoding
RbAp48273-425, which contains carboxyl-terminal WD repeats
4 through 7 (GST-RbAp48273-425), and a GST fusion protein
containing full-length RbAp48 (GST-RbAp48) were coupled to
glutathione-agarose beads and incubated with HeLa cell nuclear
extracts. CBP bound to the GST-RbAp48 fusion proteins was visualized by
Western blotting. (b) Association of CBP and RbAp48 in vivo. Endogenous
RbAp48 was immunoprecipitated from HeLa cell nuclear extracts using a
monoclonal antibody against RbAp48. CBP coimmunoprecipitated with
RbAp48 and was visualized by Western blotting. Normal mouse
immunoglobulin G (IgG) was used as a negative control.
|
|
The association of RbAp48 and CBP is augmented by phosphorylated
CREB.
We next performed GST pull-down assays using
GST-CBP551-682 and GST alone to determine whether
recombinant RbAp48 interacts with CBP directly. His-tagged RbAp48 and
RbAp46 were expressed in bacteria, purified on a nickel affinity
column, and incubated with the two GST fusion proteins. Both RbAp48 and
RbAp46 bound directly to GST-CBP551-682 (Fig.
3a). The carboxyl-terminal portion of the
RbAp48 protein that was identified in the yeast three-hybrid screen was
also able to bind directly to GST-CBP551-682 (data not
shown).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Augmentation of RbAp48-CBP interaction by phosphorylated
CREB. (a) Direct binding of RbAp48 and RbAp46 to CBP. GST pull-down
assays were performed with GST or GST-CBP551-682 and
recombinant His-tagged RbAp48 or -46. RbAp48 or -46 bound to
GST-CBP551-682 was visualized by Western blotting. (b)
Binding of RbAp48 to the phosphorylated CREB-CBP complex. GST- or
GST-CBP551-682-coupled beads were incubated with
His-tagged RbAp48 in the presence of nonphosphorylated (+CREB) or
phosphorylated (+pCREB) CREB. The binding of RbAp48 and CREB to
GST-CBP551-682 was visualized by Western blotting.
|
|
Our initial yeast assays demonstrated that RbAp48 associates more
strongly with the phosphorylated CREB-CBP complex than with CBP alone.
The interaction of RbAp48 with LexA-CBP was easily detectable in yeast,
however, and as indicated above, purified recombinant RbAp48 bound to
GST-CBP551-682 in vitro. One explanation for our failure
to identify RbAp48 in a standard two-hybrid screen using LexA-CBP as
bait may relate to the large number of false positives. The addition of
phosphorylated CREB could potentially decrease the abundance of
aberrant CBP structures that generate these false interactions.
Alternatively, phosphorylated CREB might contribute directly to the
RbAp48 interaction interface, either by inducing a necessary structure
in CBP or by providing protein interaction sites itself.
Because we are unable to compare the affinities of RbAp48 for the
LexA-CBP and LexA-CREB-YeACBP constructs in yeast due to their
different background activities, we cannot distinguish between these
models. To resolve this issue, we assayed the binding of purified
recombinant CBP and RbAp48 in vitro in the presence of nonphosphorylated or phosphorylated CREB. As previously reported, CREB
binds to GST-CBP551-682 only after phosphorylation (Fig.
3b). Consistent with our studies with yeast, we did not detect binding
of nonphosphorylated or phosphorylated CREB to GST-RbAp48 (data
not shown). Surprisingly, we found that the addition of
phosphorylated CREB greatly increased the binding of RbAp48 to
GST-CBP551-682 (Fig. 3b). Binding of RbAp48 to GST alone was not detected, even in the presence of phosphorylated CREB. This is
consistent with the hypothesis that phosphorylated CREB induces or
stabilizes a particular structure in CBP that favors interaction with
RbAp48. Alternatively, it is possible that RbAp48 also interacts with
CREB structures that have been induced by association with CBP.
RbAp48 bridges CBP to histone proteins.
The physical
association of CBP and RbAp48 and the functional characterization
of these proteins as histone acetyltransferases and histone binding
factors suggest that RbAp48 allows CBP to associate with its histone
substrates. As described above, a similar function has been
proposed for RbAp46 in the context of cytoplasmic Hat1 (50).
To test whether RbAp48 bridges CBP to histones, we isolated
hypoacetylated core histones and mononucleosomes from chicken blood and
performed pull-down assays using GST-CBP551-682 and GST
alone. These GST proteins were incubated with chicken core histones or
mononucleosomes in the presence or absence of recombinant RbAp48. Bound
proteins were detected by Western blotting using antibodies specific
for RbAp48, H3, or H4. RbAp48 associated with
GST-CBP551-682 but not GST alone (data not shown). As
shown in Fig. 4a, the binding of histone
octamers to GST-CBP551-682 was dramatically enhanced by
the addition of RbAp48. Histone octamer binding was also stimulated by
RbAp46 (data not shown). These results suggest that CBP, RbAp48, and
core histones are capable of forming a stable ternary complex.
Relatively little binding of histone proteins to CBP was detected in
the absence of RbAp48.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Bridging of CBP to histone proteins by RbAp48. GST- or
GST-CBP551-682-coupled beads were incubated with chicken
core histones (a) or mononucleosomes (b) in the presence or absence of
full-length RbAp48. Bound core histone octamers were assayed by Western
blotting using antibody specific for histone H4 (core histones). Bound
mononucleosomes were detected by two antibodies against either H3 or H4
(mononucleosomes).
|
|
Similar results were obtained when experiments were performed using
intact mononucleosomes rather than core histones (Fig. 4b). We
interpret these data to indicate that histone binding factor RbAp48
targets nucleosomal components to the CBP histone acetyltransferase.
Although the conditions utilized in these studies should maintain
mononucleosome integrity, we cannot completely rule out the possibility
that some of the histone binding resulted from the release of core
histones from the mononucleosome particles, however.
RbAp48 increases CBP histone acetylation activity.
Given the
association of CBP, RbAp48, and core histones, one obvious question is
whether RbAp48 affects CBP histone acetyltransferase activity.
Acetylation assays were performed using purified, baculovirus-expressed full-length CBP, excess [3H]AcCoA, a fivefold molar
excess of RbAp48 or BSA over CBP, and various concentrations of chicken
core histones as the substrate. Neither RbAp48 nor BSA had intrinsic
histone acetylase activity, and neither was a substrate for the CBP
acetyltransferase (data not shown). Because CBP acetylates itself, data
were corrected by subtracting the self-acetylation activity. RbAp48
treatment did not affect CBP self-acetylation (data not shown).
Results from three independent experiments demonstrated that RbAp48
augmented the acetyltransferase activity of CBP at low histone
concentrations but not at higher histone concentrations. When the data
were analyzed by the Michaelis-Menten equation, RbAp48 was found to
lower the Km by three- to fourfold but had relatively little effect on the Vmax (Table
1). This mode of activation is consistent
with a model wherein RbAp48 bridges the histone substrates to the CBP
enzyme. RbAp48 also increased the ability of CBP to acetylate intact
nucleosomes (data not shown). The ability of RbAp48 to augment CBP
histone acetyltransferase activity is reminiscent of its effect on
cytoplasmic Hat1.
Histone binding to the CBP-RbAp48 complex is blocked by
acetylation.
To assess the specificity of the RbAp48-histone
interaction, we examined the effect of acetylation on histone binding.
Chicken core histones are largely underacetylated (3) but
can be acetylated by incubation with baculovirus-expressed CBP.
GST pull-down assays were performed using
GST-CBP551-682 or GST in the presence or absence of
RbAp48 and acetylated versus underacetylated histones. Compared to the
underacetylated core histones, the acetylated histones bound to the
GST-CBP551-682-RbAp48 complex relatively poorly (Fig.
5a). Mock-acetylated histones (treated
with CBP in the absence of AcCoA) showed the same binding pattern as
the underacetylated histone proteins (data not shown). Similar
experiments were performed using acetylated versus underacetylated
mononucleosomes (Fig. 5b). These experiments showed that only
underacetylated mononucleosomes interacted with the
GST-CBP551-682-RbAp48 complex. Although the CREB binding
motif of CBP did not interact with histones, the possibility exists
that full-length CBP contains an additional domain that contacts
histone particles directly. However, because GST-RbAp48 was able to
directly bind to either core histones or mononucleosomes in an
acetylation-sensitive manner (Fig. 5c), we think it more likely that
the binding of histone particles to the CBP-RbAp48 complex occurs
through RbAp48. Thus, the association of histones with the CBP-RbAp48
complex is dependent on their acetylation status, such that the
acetylated histone particles fail to associate or readily dissociate
from the CBP-RbAp48 complexes.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Blockage of histone binding to the CBP-RbAp48 complex by
acetylation. Core histone octamers (a) and mononucleosomes (b) were
acetylated by CBP. GST pull-down assays were performed using GST or
GST-CBP551-682 in the presence or absence of RbAp48 with
acetylated versus underacetylated histone particles. (c) Both
hypoacetylated (underacetylated) and CBP-acetylated (acetylated) core
histones or mononucleosomes were incubated with GST- or
GST-RbAp48-coupled beads directly. Bound core histone octamers were
assayed by Western blotting using an antibody specific for histone H4
(histones). Bound mononucleosomes were detected by two antibodies
against either H3 or H4 (mononucleosomes).
|
|
RbAp46 facilitates p300-mediated transcription of a chromatinized
template.
We used a reconstituted chromatin template to examine
the functional contributions of RbAp46 to acetylation-dependent,
p300-mediated transcription. Productive transcription assays
(31) were performed on a chromatinized template that
contained five Gal4 DNA-binding sites upstream from the adenovirus MLP
and a 390-nt G-free cassette (26). A Gal4-VP16 fusion
protein was used to remodel the chromatin templates. We assayed the
effects of adding p300 and RbAp46 in the presence and absence of AcCoA.
The addition of p300 in the presence or absence of AcCoA did not
significantly stimulate transcription above the levels obtained with
Gal-VP16 alone (Fig. 6a and data not
shown). Supplementation of the transcription reaction mixtures with
RbAp46 modestly increased the synthesis of the 390-nt product in the
presence or absence of exogenous p300 (Fig. 6a). It should be noted,
however, that the HeLa cell nuclear extract contains significant levels
of both CBP and p300, so it is not possible to assay the contribution
of RbAp46 in the complete absence of a coactivator. Unfortunately,
stripping the extracts of CBP/p300 removes other factors required for
transcription (54). A similar increase was detected in the
presence of RbAp46 and AcCoA. The highest level of expression was seen
in the presence of AcCoA, RbAp46, and p300 (Fig. 6a), which suggests
that the activity of RbAp46 depends upon its ability to augment the CBP
histone acetyltransferase function. This stimulation of transcription
was also observed when RbAp48 was substituted for RbAp46 (data not
shown).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 6.
Facilitation of p300-mediated transcription of a
chromatinized template by RbAp46. (a) In vitro transcription assays
performed using Gal-VP16-remodeled chromatin templates. The DNA
template contains five Gal4 DNA binding sites upstream from the
adenovirus MLP and a 390-nt G-free transcription cassette. Addition of
AcCoA alone or p300 and AcCoA did not significantly enhance
transcription. Addition of p300 and RbAp46 modestly activated
transcription, while addition of p300, RbAp46, and AcCoA significantly
increased the transcription levels of the 390-nt transcript. Similar
results were obtained in four independent assays. (b) In vitro
transcription assays using a naked DNA template. The DNA template
contains five Gal4 DNA binding sites upstream from the adenovirus MLP
and a 390-nt G-free transcription cassette. As an RNA recovery control,
a DNA template encoding a 170-nt G-free transcription cassette placed
downstream from the adenovirus MLP was used in the
productive-transcription assays. When results were normalized with the
MLP control, no significant increase in transcription was detected
among the different manipulations. These results were obtained in three
independent assays.
|
|
As a control, in vitro transcription assays were also performed using
naked DNA templates. Neither 5× Gal4-MLP- nor MLP-driven transcription
was significantly stimulated by the addition of AcCoA, RbAp46, and p300
(Fig. 6b). This contrast in the effects of RbAp46 in the presence of
naked versus chromatinized templates supports the hypothesis that
RbAp46 mediates the selective targeting of CBP acetyltransferase
activity toward histones.
 |
DISCUSSION |
As a prototypical transcriptional coactivator, CBP and its
homologue p300 have important roles in gene regulation, potentially integrating signals from diverse transcriptional pathways.
Consequently, CBP and p300 have been implicated in a variety of
cellular processes, including regulation of the cell cycle,
differentiation, DNA repair, and apoptosis. Although there is evidence
that CBP and p300 interact with components of the basal transcriptional
machinery (8, 21, 29, 44), recent studies suggest that the
major activities of these coactivators occur only in the presence of
chromatin (19, 20).
Two models for this chromatin-dependent activity can be envisioned.
First, the intrinsic histone acetylation activity of CBP (or the
activities of associated histone acetyltransferases) may modify the
amino-terminal tails of histone proteins in a manner that may lead to
changes in nucleosome structure. These nucleosomal changes could result
in chromatin decondensation, which may be required for the initial
steps in transcriptional initiation. In support of this model, studies
have correlated the histone acetylation activity of CBP with its
ability to activate transcription (24). It should be noted,
however, that no direct link between histone acetylation and any
structural change in chromatin has been demonstrated. In a second
model, CBP may interact with proteins that have the potential to
mediate chromatin remodeling. While such interactions have been
proposed (16), there is no evidence that these associations
contribute to the chromatin-remodeling process. Although neither of
these models has been proven, they have a theme in common, i.e., that
chromatin-modifying proteins (histone acetyltransferases, chromatin
remodeling factors) may be localized to specific promoters through the
CBP and p300 coactivators.
The current report proposes that the nucleosome-modifying activities of
a coactivator can, in fact, be augmented by transcription factor
binding. We envisage that this occurs through the formation of new
protein interaction surfaces. This idea is supported by nuclear
magnetic resonance analysis of the phosphorylated CREB-CBP complex,
which shows that structure is induced into both components of the
complex upon their interaction (37). We had previously determined that an uncharacterized kinase in yeast is capable of
recognizing Ser133 of CREB, the same site that is critical for the interaction with CBP. This allowed us to generate CREB-CBP complexes for use as bait to screen cDNA expression libraries. One of
the strongest interactors identified in this screen was histone-binding
factor RbAp48. Subsequent control studies were performed to determine
whether both components of the bait were required for the RbAp48
interaction. These experiments indicated that while RbAp48 can bind to
CBP alone, the association is much stronger in the presence of
phosphorylated CREB. Thus, we conclude that RbAp48 binds preferentially
to the complex of the activated transcription factor and its
coactivator. This model is somewhat reminiscent of the transcription
factor-mediated activation of the peroxisome proliferator-activated
receptor
coactivator PGC-1 recently reported by Puigserver et al.
(34).
RbAp48 and its homologue RbAp46 have been characterized as components
of four distinct complexes involved in nucleosome assembly or
modification, the type B histone acetyltransferases, CAF-1, the HDACs,
and NURF (13, 18, 25, 33, 46, 49, 51, 55). For example, the
type B histone acetyltransferases have been shown to contain two
subunits, the catalytic subunit Hat1p and the RbAp48-like factor Hat2p
(33). Hat2p enhances Hat1p activity by increasing the
affinity for histone H4 (33). Hat2p is structurally related
to Cac3p, the small subunit of CAF-1 (18). In humans, this
activity is provided by RbAp48 (51). In contrast, human
Hat1 is associated with RbAp46 (50). Both RbAp46 and RbAp48 copurify with HDAC1 and HDAC2 (13, 46, 55). Finally, the ATP-dependent nucleosomal remodeling factor NURF contains a 55-kDa subunit (p55) that is highly related to both RbAp proteins
(25). Although the NURF complex does not contain histone
acetyltransferase activity, recombinant p55 associates with factors in
Drosophila nuclear extracts that can acetylate histones H3
and H4 (25). Our studies indicate that the CREB-CBP complex
associates with both RbAp48 and RbAp46.
Despite their association with various histone-modifying complexes, the
functional roles of the RbAp48 and RbAp46 proteins remain unclear. For
example, CAF-1 complexes lacking RbAp48 still can associate with
histones while human Hat1 lacking RbAp46 cannot (50). It is
perhaps more puzzling that the RbAp48/46 proteins appear to interact
with a region of histone H4 (aa 31 to 40) predicted from the
crystallographic structure of the nucleosome to be inaccessible for
binding (50). The type B acetyltransferases and CAF-1 are involved in de novo chromatin assembly; thus, the participation of
RbAp48 in histone recognition in these instances is easy to rationalize. The involvement of RbAp48 in transcriptional regulation is
obviously more problematic because the target histone sites are
embedded within chromatin. Nonetheless, our data indicate that RbAp48
bound to CBP can associate with histone proteins in the context of
nucleosomes and the same is presumably true of the RbAp48 and RbAp46
proteins associated with the HDACs. Although we cannot conclusively
exclude the possibility of a slow partial dissociation of the
mononucleosomes in our sample preparation (12), the
demonstration that RbAp48 stimulates both CBP-mediated acetylation of
nucleosomes and transcription from chromatin templates supports our
hypothesis that the nucleosome may be capable of adopting an
alternative configuration that is permissive for RbAp48 binding.
The Vmax and Km values
for CBP enzymatic activity were not markedly different from those
measured for other histone acetyltransferases. The
Vmax for CBP was slightly higher than that for
GCN5, for example (s
1 = 0.3 versus 0.08),
possibly due to the fact that the GCN5 fragment examined represented
only the catalytic domain (45). In the absence of RbAp48,
the Km values of GCN5 and CBP were very similar (28 versus 16 µM). Addition of RbAp48 lowered the
Km of CBP for the histone substrate to about 6 µM. Somewhat unexpected was the finding that RbAp48 bound to CBP
recognized underacetylated but not acetylated histones. Although it has
not been tested explicitly, the RbAp48 and RbAp46 proteins in the HDACs
would be expected to recognize predominantly acetylated histones. It is
possible that the binding specificities of RbAp48 and RbAp46 depend
upon whether they are associated with histone acetylases or deacetylases.
The ability of RbAp48 to augment CBP histone acetyltransferase function
appears to be reflected by an increase in transcriptional activity.
Using in vitro transcription assays, we were able to demonstrate that
transcription from a reconstituted chromatin template was stimulated
upon addition of p300, RbAp46, and AcCoA. This enhancement is specific
for chromatin templates, suggesting that RbAp48 and CBP act in concert
to alter the acetylation state of nucleosomal histones. These assays
utilized a Gal-VP16 activator to remodel the chromatin template. VP16
binds to CBP and p300 (52), and p300 activation of Gal-VP16
has been observed by other investigators (20). Addition of
p300 and AcCoA alone did not activate transcription above the basal
levels achieved by Gal-VP16 in our assays, and addition of p300 and
RbAp46 only modestly stimulated transcription. The requirement for all
three components implicates CBP's histone acetylation function in
transcriptional activation. The acetyltransferase activity of CBP is
not restricted to histones. It is possible that RbAp48 targets the
acetylation function of CBP to histones, as opposed to other targets
(11, 15).
Finally, it remains to be determined whether the ability of
phosphorylated CREB to augment RbAp48 binding to CBP is shared by other
transcriptional activators. Many additional transcription factors
interact with the CREB binding domain of CBP, some dependent upon
phosphorylation and some in a phosphorylation-independent manner. Three
such phosphorylation-independent factors, c-myb, SREBP, and
Drosophila cubitus interruptus, have been proposed to
interact with CBP through an alpha-helical interface related to that of
phosphorylated CREB in the CREB-CBP complex (4, 32),
suggesting that similar protein interaction surfaces can be generated.
Whether complexes containing these other transcription factors also
bind RbAp48 is unknown.
 |
ACKNOWLEDGMENTS |
Q. Zhang and N. Vo contributed equally to this study.
We thank Phyllis Goldman for construction of yeast bait constructs and
help with the three-hybrid assay; Stan Hollenberg for the VP16 cDNA
library; Danny Reinberg, Alejandra Loyola, and Gary LeRoy for
instructions on chromatin assembly and in vitro transcription; and John
Denu, W. Lee Kraus, Roland Kwok, Richard Mauer, Marc Monestier, Bruce
Stillman, and Michael Wigler for reagents.
This work was supported by grants from the NIH.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Vollum
Institute, Oregon Health Sciences University, 3181 S.W. Sam Jackson
Park Rd., Portland, OR 97201. Phone: (503) 494-5078. Fax: (503)
494-4353. E-mail: goodmanr{at}ohsu.edu.
 |
REFERENCES |
| 1.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1990.
Current protocols in molecular biology, p. 12.1.1-12.1.9.
John Wiley & Sons, Inc., New York, N.Y.
|
| 2.
|
Bannister, A. J., and T. Kouzarides.
1996.
The CBP co-activator is a histone acetyltransferase.
Nature
384:641-643[CrossRef][Medline].
|
| 3.
|
Brotherton, T. W.,
J. Covault,
A. Shires, and R. Chalkley.
1981.
Only a small fraction of avian erythrocyte histone is involved in ongoing acetylation.
Nucleic Acids Res.
9:5061-5073[Abstract/Free Full Text].
|
| 4.
|
Cardinaux, J.-R.,
J. C. Notis,
Q. Zhang,
N. Vo,
J. C. Craig,
D. M. Fass,
R. G. Brennan, and R. H. Goodman.
2000.
Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation.
Mol. Cell. Biol.
20:1546-1552[Abstract/Free Full Text].
|
| 5.
|
Chen, H.,
R. J. Lin,
R. L. Schiltz,
D. Chakravarti,
A. Nash,
L. Nagy,
M. L. Privalsky,
Y. Nakatani, and R. M. Evans.
1997.
Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.
Cell
90:569-580[CrossRef][Medline].
|
| 6.
|
Chrivia, J. C.,
R. P. Kwok,
N. Lamb,
M. Hagiwara,
M. R. Montminy, and R. H. Goodman.
1993.
Phosphorylated CREB binds specifically to the nuclear protein CBP.
Nature
365:855-859[CrossRef][Medline].
|
| 7.
|
Eckner, R.,
M. E. Ewen,
D. Newsome,
M. Gerdes,
J. A. DeCaprio,
J. B. Lawrence, and D. M. Livingston.
1994.
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.
Genes Dev.
8:869-884[Abstract/Free Full Text].
|
| 8.
|
Felzien, L. K.,
S. Farrell,
J. C. Betts,
R. Mosavin, and G. J. Nabel.
1999.
Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator.
Mol. Cell. Biol.
19:4241-4246[Abstract/Free Full Text].
|
| 9.
|
Feng, H. P.,
D. S. Scherl, and J. Widom.
1993.
Lifetime of the histone octamer studied by continuous-flow quasielastic light scattering: test of a model for nucleosome transcription.
Biochemistry
32:7824-7831[CrossRef][Medline].
|
| 10.
|
Fondell, J. D.,
H. Ge, and R. G. Roeder.
1996.
Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.
Proc. Natl. Acad. Sci. USA
93:8329-8333[Abstract/Free Full Text].
|
| 11.
|
Gu, W., and R. G. Roeder.
1997.
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
Cell
90:595-606[CrossRef][Medline].
|
| 12.
|
Hansen, J. C.,
J. Ausio,
V. H. Stanik, and K. E. van Holde.
1989.
Homogeneous reconstituted oligonucleosomes, evidence for salt-dependent folding in the absence of histone H1.
Biochemistry
28:9129-9136[CrossRef][Medline].
|
| 13.
|
Hassig, C. A.,
T. C. Fleischer,
A. N. Billin,
S. L. Schreiber, and D. E. Ayer.
1997.
Histone deacetylase activity is required for full transcriptional repression by mSin3A.
Cell
89:341-347[CrossRef][Medline].
|
| 14.
|
Hill, J.,
K. A. Donald,
D. E. Griffiths, and G. Donald.
1991.
DMSO-enhanced whole cell yeast transformation.
Nucleic Acids Res.
19:5791[Free Full Text].
|
| 15.
|
Imhof, A.,
X. J. Yang,
V. V. Ogryzko,
Y. Nakatani,
A. P. Wolffe, and H. Ge.
1997.
Acetylation of general transcription factors by histone acetyltransferases.
Curr. Biol.
7:689-692[CrossRef][Medline].
|
| 16.
|
Johnston, H.,
J. Kneer,
I. Chackalaparampil,
P. Yaciuk, and J. Chrivia.
1999.
Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein.
J. Biol. Chem.
274:16370-16376[Abstract/Free Full Text].
|
| 17.
|
Kamakaka, R. T.,
M. Bulger, and J. T. Kadonaga.
1993.
Potentiation of RNA polymerase II transcription by Gal4-VP16 during but not after DNA replication and chromatin assembly.
Genes Dev.
7:1779-1795[Abstract/Free Full Text].
|
| 18.
|
Kaufman, P. D.,
R. Kobayashi, and B. Stillman.
1997.
Ultraviolet radiation sensitivity and reduction of telomeric silencing in Saccharomyces cerevisiae cells lacking chromatin assembly factor-I.
Genes Dev.
11:345-357[Abstract/Free Full Text].
|
| 19.
|
Kraus, W. L., and J. T. Kadonaga.
1998.
p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation.
Genes Dev.
12:331-342[Abstract/Free Full Text].
|
| 20.
|
Kraus, W. L.,
E. T. Manning, and J. T. Kadonaga.
1999.
Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates.
Mol. Cell. Biol.
19:8123-8135[Abstract/Free Full Text].
|
| 21.
|
Kwok, R. P.,
J. R. Lundblad,
J. C. Chrivia,
J. P. Richards,
H. P. Bachinger,
R. G. Brennan,
S. G. Roberts,
M. R. Green, and R. H. Goodman.
1994.
Nuclear protein CBP is a coactivator for the transcription factor CREB.
Nature
370:223-226[CrossRef][Medline].
|
| 22.
|
Laurance, M. E.,
R. P. Kwok,
M. S. Huang,
J. P. Richards,
J. R. Lundblad, and R. H. Goodman.
1997.
Differential activation of viral and cellular promoters by human T-cell lymphotropic virus-1 tax and cAMP-responsive element modulator isoforms.
J. Biol. Chem.
272:2646-2651[Abstract/Free Full Text].
|
| 23.
|
Li, Q.,
A. Imhof,
T. N. Collingwood,
F. D. Urnov, and A. P. Wolffe.
1999.
p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption.
EMBO J.
18:5634-5652[CrossRef][Medline].
|
| 24.
|
Martinez-Balbas, M. A.,
A. J. Bannister,
K. Martin,
P. Haus-Seuffert,
M. Meisterernst, and T. Kouzarides.
1998.
The acetyltransferase activity of CBP stimulates transcription.
EMBO J.
17:2886-2893[CrossRef][Medline].
|
| 25.
|
Martinez-Balbas, M. A.,
T. Tsukiyama,
D. Gdula, and C. Wu.
1998.
Drosophila NURF-55, a WD repeat protein involved in histone metabolism.
Proc. Natl. Acad. Sci. USA
95:132-137[Abstract/Free Full Text].
|
| 26.
|
Merino, A.,
K. R. Madden,
W. S. Lane,
J. J. Champoux, and D. Reinberg.
1993.
DNA topoisomerase I is involved in both repression and activation of transcription.
Nature
365:227-232[CrossRef][Medline].
|
| 27.
|
Montminy, M.
1997.
Transcriptional regulation by cyclic AMP.
Annu. Rev. Biochem.
66:807-822[CrossRef][Medline].
|
| 28.
|
Naar, A. M.,
P. A. Beaurang,
S. Zhou,
S. Abraham,
W. Solomon, and R. Tjian.
1999.
Composite co-activator ARC mediates chromatin-directed transcriptional activation.
Nature
398:828-832[CrossRef][Medline].
|
| 29.
|
Nakajima, T.,
C. Uchida,
S. F. Anderson,
C. G. Lee,
J. Hurwitz,
J. D. Parvin, and M. Montminy.
1997.
RNA helicase A mediates association of CBP with RNA polymerase II.
Cell
90:1107-1112[CrossRef][Medline].
|
| 30.
|
Ogryzko, V. V.,
R. L. Schiltz,
V. Russanova,
B. H. Howard, and Y. Nakatani.
1996.
The transcriptional coactivators p300 and CBP are histone acetyltransferases.
Cell
87:953-959[CrossRef][Medline].
|
| 31.
|
Orphanides, G.,
G. LeRoy,
C. H. Chang,
D. S. Luse, and D. Reinberg.
1998.
FACT, a factor that facilitates transcript elongation through nucleosomes.
Cell
92:105-116[CrossRef][Medline].
|
| 32.
|
Parker, D.,
M. Rivera,
T. Zor,
A. Henrion-Caude,
I. Radhakrishnan,
A. Kumar,
L. H. Shapiro,
P. E. Wright,
M. Montminy, and P. K. Brindle.
1999.
Role of secondary structure in discrimination between constitutive and inducible activators.
Mol. Cell. Biol.
19:5601-5607[Abstract/Free Full Text].
|
| 33.
|
Parthun, M. R.,
J. Widom, and D. E. Gottschling.
1996.
The major cytoplasmic histone acetyltransferase in yeast: links to chromatin replication and histone metabolism.
Cell
87:85-94[CrossRef][Medline].
|
| 34.
|
Puigserver, P.,
G. Adelmant,
Z. Wu,
M. Fan,
J. Xu,
B. O'Malley, and B. M. Spiegelman.
1999.
Activation of PPARgamma coactivator-1 through transcription factor docking.
Science
286:1368-1371[Abstract/Free Full Text].
|
| 35.
|
Qian, Y. W.,
Y. C. Wang,
R. E. Hollingsworth, Jr.,
D. Jones,
N. Ling, and E. Y. Lee.
1993.
A retinoblastoma-binding protein related to a negative regulator of Ras in yeast.
Nature
364:648-652[CrossRef][Medline].
|
| 36.
|
Rachez, C.,
B. D. Lemon,
Z. Suldan,
V. Bromleigh,
M. Gamble,
A. M. Naar,
H. Erdjument-Bromage,
P. Tempst, and L. P. Freedman.
1999.
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.
Nature
398:824-828[CrossRef][Medline].
|
| 37.
|
Radhakrishnan, I.,
G. C. Perez-Alvarado,
D. Parker,
H. J. Dyson,
M. R. Montminy, and P. E. Wright.
1997.
Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions.
Cell
91:741-752[CrossRef][Medline].
|
| 38.
|
Richards, J. P.,
H. P. Bachinger,
R. H. Goodman, and R. G. Brennan.
1996.
Analysis of the structural properties of cAMP-responsive element-binding protein (CREB) and phosphorylated CREB.
J. Biol. Chem.
271:13716-13723[Abstract/Free Full Text].
|
| 39.
|
Schiestl, R. H., and R. D. Gietz.
1989.
High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier.
Curr. Genet.
16:339-346[CrossRef][Medline].
|
| 40.
|
Shaywitz, A. J., and M. E. Greenberg.
1999.
CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.
Annu. Rev. Biochem.
68:821-861[CrossRef][Medline].
|
| 41.
|
Shih, H. M.,
P. S. Goldman,
A. J. DeMaggio,
S. M. Hollenberg,
R. H. Goodman, and M. F. Hoekstra.
1996.
A positive genetic selection for disrupting protein-protein interactions: identification of CREB mutations that prevent association with the coactivator CBP.
Proc. Natl. Acad. Sci. USA
93:13896-13901[Abstract/Free Full Text].
|
| 42.
|
Shikama, M.,
J. Lyon, and N. B. Thangue.
1997.
The p300/CBP family: integrating signals with transcription factors and chromatin.
Trends Cell Biol.
7:230-236.
|
| 43.
|
Spencer, T. E.,
G. Jenster,
M. M. Burcin,
C. D. Allis,
J. Zhou,
C. A. Mizzen,
N. J. McKenna,
S. A. Onate,
S. Y. Tsai,
M. J. Tsai, and B. W. O'Malley.
1997.
Steroid receptor coactivator-1 is a histone acetyltransferase.
Nature
389:194-198[CrossRef][Medline].
|
| 44.
|
Swope, D. L.,
C. L. Mueller, and J. C. Chrivia.
1996.
CREB-binding protein activates transcription through multiple domains.
J. Biol. Chem.
271:28138-28145[Abstract/Free Full Text].
|
| 45.
|
Tanner, K. G.,
R. C. Trievel,
M. H. Kuo,
R. M. Howard,
S. L. Berger,
C. D. Allis,
R. Marmorstein, and J. M. Denu.
1999.
Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional coactivator.
J. Biol. Chem.
274:18157-18160[Abstract/Free Full Text].
|
| 46.
|
Taunton, J.,
C. A. Hassig, and S. L. Schreiber.
1996.
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p.
Science
272:408-411[Abstract].
|
| 47.
|
Torchia, J.,
D. W. Rose,
J. Inostroza,
Y. Kamei,
S. Westin,
C. K. Glass, and M. G. Rosenfeld.
1997.
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.
Nature
387:677-684[CrossRef][Medline].
|
| 48.
|
Tse, C.,
E. I. Georgieva,
A. B. Ruiz-Garcia,
R. Sendra, and J. C. Hansen.
1998.
Gcn5p, a transcription-related histone acetyltransferase, acetylates nucleosomes and folded nucleosomal arrays in the absence of other protein subunits.
J. Biol. Chem.
273:32388-32392[Abstract/Free Full Text].
|
| 49.
|
Tyler, J. K.,
M. Bulger,
R. T. Kamakaka,
R. Kobayashi, and J. T. Kadonaga.
1996.
The p55 subunit of Drosophila chromatin assembly factor 1 is homologous to a histone deacetylase-associated protein.
Mol. Cell. Biol.
16:6149-6159[Abstract].
|
| 50.
|
Verreault, A.,
P. D. Kaufman,
R. Kobayashi, and B. Stillman.
1998.
Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase.
Curr. Biol.
8:96-108[CrossRef][Medline].
|
| 51.
|
Verreault, A.,
P. D. Kaufman,
R. Kobayashi, and B. Stillman.
1996.
Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4.
Cell
87:95-104[CrossRef][Medline].
|
| 52.
|
Wang, L.,
S. R. Grossman, and E. Kieff.
2000.
Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
Proc. Natl. Acad. Sci. USA
97:430-435[Abstract/Free Full Text].
|
| 53.
|
Yang, X. J.,
V. V. Ogryzko,
J. Nishikawa,
B. H. Howard, and Y. Nakatani.
1996.
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
Nature
382:319-324[CrossRef][Medline].
|
| 54.
|
Yie, J.,
K. Senger, and D. Thanos.
1999.
Mechanism by which the IFN-beta enhanceosome activates transcription.
Proc. Natl. Acad. Sci. USA
96:13108-13113[Abstract/Free Full Text].
|
| 55.
|
Zhang, Y.,
R. Iratni,
H. Erdjument-Bromage,
P. Tempst, and D. Reinberg.
1997.
Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex.
Cell
89:357-364[CrossRef][Medline].
|
Molecular and Cellular Biology, July 2000, p. 4970-4978, Vol. 20, No. 14
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Choi, H.-K., Choi, K.-C., Kang, H.-B., Kim, H.-C., Lee, Y.-H., Haam, S., Park, H.-G., Yoon, H.-G.
(2008). Function of Multiple Lis-Homology Domain/WD-40 Repeat-Containing Proteins in Feed-Forward Transcriptional Repression by Silencing Mediator for Retinoic and Thyroid Receptor/Nuclear Receptor Corepressor Complexes. Mol. Endocrinol.
22: 1093-1104
[Abstract]
[Full Text]
-
Armstrong, V. J., Muzylak, M., Sunters, A., Zaman, G., Saxon, L. K., Price, J. S., Lanyon, L. E.
(2007). Wnt/beta-Catenin Signaling Is a Component of Osteoblastic Bone Cell Early Responses to Load-bearing and Requires Estrogen Receptor {alpha}. J. Biol. Chem.
282: 20715-20727
[Abstract]
[Full Text]
-
Tie, F., Stratton, C. A., Kurzhals, R. L., Harte, P. J.
(2007). The N Terminus of Drosophila ESC Binds Directly to Histone H3 and Is Required for E(Z)-Dependent Trimethylation of H3 Lysine 27. Mol. Cell. Biol.
27: 2014-2026
[Abstract]
[Full Text]
-
Ishimaru, N., Arakaki, R., Omotehara, F., Yamada, K., Mishima, K., Saito, I., Hayashi, Y.
(2006). Novel Role for RbAp48 in Tissue-Specific, Estrogen Deficiency-Dependent Apoptosis in the Exocrine Glands. Mol. Cell. Biol.
26: 2924-2935
[Abstract]
[Full Text]
-
Zhang, Q., Nottke, A., Goodman, R. H.
(2005). Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc. Natl. Acad. Sci. USA
102: 2802-2807
[Abstract]
[Full Text]
-
Kim, D.-W., Lassar, A. B.
(2003). Smad-Dependent Recruitment of a Histone Deacetylase/Sin3A Complex Modulates the Bone Morphogenetic Protein-Dependent Transcriptional Repressor Activity of Nkx3.2. Mol. Cell. Biol.
23: 8704-8717
[Abstract]
[Full Text]
-
Hong, R., Chakravarti, D.
(2003). The Human Proliferating Cell Nuclear Antigen Regulates Transcriptional Coactivator p300 Activity and Promotes Transcriptional Repression. J. Biol. Chem.
278: 44505-44513
[Abstract]
[Full Text]
-
Deng, Z., Chen, C.-J., Chamberlin, M., Lu, F., Blobel, G. A., Speicher, D., Cirillo, L. A., Zaret, K. S., Lieberman, P. M.
(2003). The CBP Bromodomain and Nucleosome Targeting Are Required for Zta-Directed Nucleosome Acetylation and Transcription Activation. Mol. Cell. Biol.
23: 2633-2644
[Abstract]
[Full Text]
-
Li, F., Macfarlan, T., Pittman, R. N., Chakravarti, D.
(2002). Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities. J. Biol. Chem.
277: 45004-45012
[Abstract]
[Full Text]
-
Nagarajan, U. M., Bushey, A., Boss, J. M.
(2002). Modulation of Gene Expression by the MHC Class II Transactivator. J. Immunol.
169: 5078-5088
[Abstract]
[Full Text]
-
Goto, N. K., Zor, T., Martinez-Yamout, M., Dyson, H. J., Wright, P. E.
(2002). Cooperativity in Transcription Factor Binding to the Coactivator CREB-binding Protein (CBP). THE MIXED LINEAGE LEUKEMIA PROTEIN (MLL) ACTIVATION DOMAIN BINDS TO AN ALLOSTERIC SITE ON THE KIX DOMAIN. J. Biol. Chem.
277: 43168-43174
[Abstract]
[Full Text]
-
Asahara, H., Tartare-Deckert, S., Nakagawa, T., Ikehara, T., Hirose, F., Hunter, T., Ito, T., Montminy, M.
(2002). Dual Roles of p300 in Chromatin Assembly and Transcriptional Activation in Cooperation with Nucleosome Assembly Protein 1 In Vitro. Mol. Cell. Biol.
22: 2974-2983
[Abstract]
[Full Text]
-
Seo, S.-b., Macfarlan, T., McNamara, P., Hong, R., Mukai, Y., Heo, S., Chakravarti, D.
(2002). Regulation of Histone Acetylation and Transcription by Nuclear Protein pp32, a Subunit of the INHAT Complex. J. Biol. Chem.
277: 14005-14010
[Abstract]
[Full Text]
-
Blobel, G. A.
(2002). CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J. Leukoc. Biol.
71: 545-556
[Full Text]
-
Hoffmann, R., Seidl, T., Neeb, M., Rolink, A., Melchers, F.
(2002). Changes in Gene Expression Profiles in Developing B Cells of Murine Bone Marrow. Genome Res
12: 98-111
[Abstract]
[Full Text]
-
Yang, E. J., Ahn, Y. S., Chung, K. C.
(2001). Protein Kinase Dyrk1 Activates cAMP Response Element-binding Protein during Neuronal Differentiation in Hippocampal Progenitor Cells. J. Biol. Chem.
276: 39819-39824
[Abstract]
[Full Text]
-
Vo, N., Fjeld, C., Goodman, R. H.
(2001). Acetylation of Nuclear Hormone Receptor-Interacting Protein RIP140 Regulates Binding of the Transcriptional Corepressor CtBP. Mol. Cell. Biol.
21: 6181-6188
[Abstract]
[Full Text]
-
Manning, E. T., Ikehara, T., Ito, T., Kadonaga, J. T., Kraus, W. L.
(2001). p300 Forms a Stable, Template-Committed Complex with Chromatin: Role for the Bromodomain. Mol. Cell. Biol.
21: 3876-3887
[Abstract]
[Full Text]
-
Ernst, P., Wang, J., Huang, M., Goodman, R. H., Korsmeyer, S. J.
(2001). MLL and CREB Bind Cooperatively to the Nuclear Coactivator CREB-Binding Protein. Mol. Cell. Biol.
21: 2249-2258
[Abstract]
[Full Text]
-
Fass, D. M., Craig, J. C., Impey, S., Goodman, R. H.
(2001). Cooperative Mechanism of Transcriptional Activation by a Cyclic AMP-response Element Modulator alpha Mutant Containing a Motif for Constitutive Binding to CREB-binding Protein. J. Biol. Chem.
276: 2992-2997
[Abstract]
[Full Text]
-
Monroy, M. A., Ruhl, D. D., Xu, X., Granner, D. K., Yaciuk, P., Chrivia, J. C.
(2001). Regulation of cAMP-responsive Element-binding Protein-mediated Transcription by the SNF2/SWI-related Protein, SRCAP. J. Biol. Chem.
276: 40721-40726
[Abstract]
[Full Text]
-
Vo, N., Goodman, R. H.
(2001). CREB-binding Protein and p300 in Transcriptional Regulation. J. Biol. Chem.
276: 13505-13508
[Full Text]